Tranche size and terms
The announcement was released through RNS on November 3, 2026, with final terms dated November 4. It covers Tranche 371 of Series 5, identified by ISIN DE000A2T5DZ1, with a scheduled maturity of May 21, 2080.
The terms put the Series 5 total at 21,476,293 securities immediately before the tranche issue date and 21,530,293 immediately afterward. The series allows for a maximum of 100,000,000,000 securities.
These euro-denominated, foreign-exchange-hedged securities give investors exposure to gold without physical delivery. Only Authorised Participants may subscribe.
Gold entitlement and annual fees
Each security carries a metal entitlement of 0.013442933 fine troy ounce at the tranche's subscription trade date, compared with an initial entitlement of 0.0155 fine troy ounce when the series began.
According to the Financial Times, the entitlement declines over time because it is reduced daily to account for the base fee and foreign-exchange hedging fee. The product's net expense ratio is 0.24% annually. An RNS summary carried by Investegate specifies the components: a 0.15% annual base fee and a 0.09% annual FX hedging fee.
The Financial Times lists May 20, 2020, as the launch date for the Ireland-domiciled Series 5 securities. It reports a fund size of GBP 909.64 million as of September 30, 2026.
Programme and issuer
The tranche falls under the Secured Xtrackers ETC Precious Metal Linked Securities Programme. According to law firm Arthur Cox LLP, the programme was established in March 2020 under Irish law. It permits exchange-traded certificates denominated in euros, pounds sterling or US dollars and linked to physical holdings of gold, silver, platinum and palladium.
A DWS / Xtrackers factsheet describes the Dublin-registered issuer as a special purpose vehicle devoted solely to issuing ETC securities. Xtrackers ETC plc was incorporated in Ireland on May 21, 2018, under registration number 627079.
The issue-specific summary identifies Wilmington Trust SP Services (Dublin) Limited as holding all of the issuer's issued shares in trust for charitable purposes. It names Eileen Starrs and Claudio Borza as managing directors and KPMG Ireland as statutory auditor.
Transaction arrangements and prospectus
For the tranche, J.P. Morgan SE serves as both Series Counterparty and Account Bank, while J.P. Morgan Chase Bank, N.A., London Branch serves as Metal Agent. The terms name Clearstream, Frankfurt as the relevant clearing system and provide for CREST indirect clearing.
The issue-specific summary lists February 12, 2026, as the base prospectus approval date. The DWS / Xtrackers factsheet says the Central Bank of Ireland approved the prospectus under Regulation (EU) 2017/1129 and that the approval was notified to authorities in Austria, Belgium, Finland, France, Germany, Italy, Luxembourg, the Netherlands, Portugal, Spain and Sweden. The factsheet also records approval by the UK Financial Conduct Authority under the UK Prospectus Regulation.
The summary cautions that it is an introduction to the base prospectus and that investment decisions should be based on the prospectus as a whole.
